Venu Madhav Chennupati wins the outstanding leadership award at Health 2.0 USA conference – Primex News Network

New Delhi (India), April 23: Health 2.0, an acclaimed healthcare event in the USA, attempts to reimagine the realm of healthcare by uniting some of the most distinguished experts from a wide range of specialities. The conference spotlights the latest developments in healthcare and wellness on its vibrant platform while promoting networking and exchanging ideas between forward-thinking individuals and companies.

Health 2.0 recognises health care experts and companies globally for their outstanding achievements in their particular field of work. Healthcare providers have been in high demand during Covid-19, especially in promoting the expansion of health care and clinical research applications in the resource-limited setting.  The event conducted in Las Vegas during April 11-13, 2022, has been to gain insights into companies and individuals in healthcare who have inspired our future healthcare providers to be prominent in their field and strive for success.

At this Health 2.0 event, Venu Madhav Chennupati was awarded the outstanding leadership award in 2022 in healthcare for his extensive services in healthcare delivery systems in India. Venu is the CEO of Pegase Health Systems and a Harvard Alumni in Public Health, working forthe past 13 years in building Healthcare Delivery Systems. The Pegase Health Systems (PHS), launched in 2009 by Venu, has delivered Tele-Health 72M consults, including 69 Million voice, 400K video and 3 Million personal consults through its system in India to date. Venu has been aiming at improving the value delivered to patients through his systems. Venu strongly believes that health care should be measured in terms of the patient outcomes achieved per dollar expended and not the number of different services provided or the volume of services delivered; more care and more expensive care are not necessarily better care.

During Covid-19, Venu has also been instrumental in filing public interest litigation in the state of Telangana to use the limited vaccination supply on the frontline workforce instead of vaccinating by demographics. During this time, Venu and Harvard professors published a research paper on the socio-economic effects on workers of prolonged quarantine/lockdown measures. Health 2.0 recognised the contributions of Venu in the public health domain and took this opportunity to award his accomplishments in this 2022 global event.

  • Related Posts

    One Analyst, 71,000 Investors: Why Ankit Jaiswal Built NiveshX

    Bengaluru (Karnataka) [India], October 29: Your groceries arrive in 20 minutes. Biryani at midnight takes 30. Yet for most Indian investors, honest research on the stock they are about to…

    CivitTDRx Enables a Digital-First Approach to Transparent TDR Transactions

    New Delhi [India], October 29: SoftTech Engineers Limited, a pioneer in AECO (Architecture, Engineering, Construction & Operations) technology and e-governance solutions, has introduced CivitTDRx — a digital TDR exchange solution…

    You Missed

    Bollywood Actor Kamlesh Sawant Takes On India’s English-Speaking Challenge in New MySivi Ad

    Bollywood Actor Kamlesh Sawant Takes On India’s English-Speaking Challenge in New MySivi Ad

    One Analyst, 71,000 Investors: Why Ankit Jaiswal Built NiveshX

    One Analyst, 71,000 Investors: Why Ankit Jaiswal Built NiveshX

    CivitTDRx Enables a Digital-First Approach to Transparent TDR Transactions

    CivitTDRx Enables a Digital-First Approach to Transparent TDR Transactions

    World Book of Records (UK) Awards & Summit in Tunisia Celebrates Global Excellence with 50 Countries and Silver Jubilee of International Siddhashram Shakti Centre, UK

    World Book of Records (UK) Awards & Summit in Tunisia Celebrates Global Excellence with 50 Countries and Silver Jubilee of International Siddhashram Shakti Centre, UK

    Lincoln Pharmaceuticals Ltd Reports Consolidated Net Profit of Rs. 57.50 crore in H1 FY27, growth of 20.52 percent Y-o-Y

    Lincoln Pharmaceuticals Ltd Reports Consolidated Net Profit of Rs. 57.50 crore in H1 FY27, growth of 20.52 percent Y-o-Y

    AtHomeCare™ Trialling Integrated App to Streamline Post-Discharge Care, Reduce Readmissions

    AtHomeCare™ Trialling Integrated App to Streamline Post-Discharge Care, Reduce Readmissions